Drug-industry representatives are descending on the capital to protect their freedom to advertise their wares directly to consumers and to push for looser government restrictions on their ability to promote off-label uses of their medicines.Click here to access the WSJ article (sub. req.).
Friday, April 18, 2008
From the Wall Street Journal article: